RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Janine Ziermann to Neoplasm Recurrence, Local

Back to Details
This is a "connection" page, showing publications Janine Ziermann has written about Neoplasm Recurrence, Local.
Janine Ziermann
Connection Strength
0.151
Neoplasm Recurrence, Local
  1. Burchert A, Saussele S, Eigendorff E, M?ller MC, Sohlbach K, Inselmann S, Sch?tz C, Metzelder SK, Ziermann J, Kostrewa P, Hoffmann J, Hehlmann R, Neubauer A, Hochhaus A. Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia. Leukemia. 2015 Jun; 29(6):1331-5.
    View in: PubMed
    Score: 0.121
  2. Frietsch JJ, Kastner C, Grunewald TG, Schweigel H, Nollau P, Ziermann J, Clement JH, La Ros?e P, Hochhaus A, Butt E. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia. Oncotarget. 2014 Jul 30; 5(14):5257-71.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support